This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Evan Smith
Introduction
Evan Smith is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that address various medical conditions. His work is characterized by a focus on improving treatment options for patients suffering from specific disorders.
Latest Patents
Evan Smith holds a patent for "CRF receptor antagonists and methods of use." This patent includes compounds, preparations, compositions, and methods aimed at treating diseases and disorders, such as congenital adrenal hyperplasia (CAH). His innovative approach has the potential to enhance therapeutic strategies in this area.
Career Highlights
Evan Smith is currently employed at Neurocrine Biosciences, Inc., where he continues to advance his research and development efforts. His work at this company has positioned him as a key player in the pharmaceutical industry, contributing to the development of new treatments.
Collaborations
Evan collaborates with talented individuals such as Sha Luo and Gordon Raphael Loewen. These partnerships enhance the research environment and foster innovation within the team.
Conclusion
Evan Smith's contributions to the field of pharmacology through his patent and work at Neurocrine Biosciences, Inc. highlight his commitment to improving patient care. His innovative spirit and collaborative efforts are paving the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile